Martinus A.H. Capelle

University of Geneva

Papers

2

Total Citations

49

H-Index

2

About

Martinus A.H. Capelle is a leading figure in biopharmaceutical process development, with a focused expertise in the formulation and handling of therapeutic proteins. His work addresses a critical bottleneck in the clinic: ensuring the stability and safety of biologic drugs during preparation. Dr. Capelle’s highly cited research, including a seminal 2008 study on high-throughput formulation screening (26 citations), pioneered methods to rapidly identify optimal conditions that prevent protein aggregation. He further advanced the field by validating automated robotic systems for compounding monoclonal antibody patient doses (2013, 23 citations), demonstrating that such automation does not compromise protein integrity. This work directly addressed the growing need for efficient, error-free drug preparation in hospitals. By bridging the gap between laboratory science and clinical practice, Dr. Capelle’s contributions have helped establish the protocols that ensure the safe administration of life-saving biologics, making him a key innovator in pharmaceutical technology.

Research Focus

Key Achievements

2
H-Index
2
Papers
49
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
High-throughput formulation screening of therapeutic proteins
26 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: University of Geneva

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago